Zydus Pharmaceuticals (USA) Inc. has received approval for its Abbreviated New Drug Application to market Glyburide and Metformin Hydrochloride, intro...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
On February 23, 2016, the FDA granted approval to Pfizer's oral TOFACITINIB CITRATE for XELJANZ XR, marking a strategic expansion of the rheumatoid ar...
# FDA Approves ScieGen Pharmaceuticals' Generic Gabapentin ScieGen Pharmaceuticals, Inc. received FDA approval for its generic gabapentin oral formul...
# FDA Approves Sagent Pharmaceuticals' Generic Fluorouracil Injection Sagent Pharmaceuticals has received FDA approval for its generic fluorouracil i...
Amneal Pharmaceuticals received FDA approval Wednesday for a supplemental ANDA to manufacture generic dexmethylphenidate (Ritalin La), an oral treatme...
# FDA Approves ANDA Submission for Accord Healthcare Accord Healthcare has received FDA approval for its abbreviated new drug application (ANDA206058...
# FDA Approves Generic Gabapentin from Creekwood Pharmaceuticals Creekwood Pharmaceuticals LLC has received FDA approval for its generic gabapentin o...
Sun Pharmaceutical Industries, Inc. announced the approval of its generic buprenorphine hydrochloride sublingual tablets to market, providing a new af...
Eugia US LLC received FDA approval for its ANDA for tranexamic acid intravenous injection (2016), a generic version of the marketed hemostatic agent. ...
Although specific details regarding the new application date are not provided, the filing of ANDA205348 by Crossmedika S.A. could potentially signal a...
# FDA Approves Macleods Pharmaceuticals' Generic Levocetirizine Dihydrochloride Macleods Pharmaceuticals Limited received FDA approval for its generi...
Amneal Pharmaceuticals LLC announced the approval of its generic valsartan application (ANDA204011) on January 11, 2016, which is expected to broaden ...
Mylan has received regulatory approval from the FDA for a new generic product through ANDA 205257, signaling a potential new revenue opportunity for t...
# FDA Approves Actelion Pharmaceuticals' UPTRAVI for Pulmonary Arterial Hypertension Actelion Pharmaceuticals US, Inc. received FDA approval for UPTR...
Lupin Pharmaceuticals, Inc. announced that the FDA approved its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Oral Solution, offering a...
WG Critical Care, LLC announces the FDA approval of their injectable generic ampicillin and sulbactam powder for intramuscular injection, supplementin...
Aurobindo Pharma received FDA approval for its generic Risedronate Sodium oral tablets, opening a new revenue opportunity within the osteoporosis mark...
Accord Healthcare Inc. received FDA approval for generic CLOZAPINE, a move that expands supply for this crucial antipsychotic treatment and is expecte...
AstraZeneca received FDA approval for TAGRISSO (osimertinib), enhancing its lung cancer portfolio and strengthening its position in the targeted thera...
ANI Pharmaceuticals, Inc. has announced the approval of the ANDA for duloxetine hydrochloride oral tablets, introducing a generic alternative to the b...